AS
Ascentage Pharma Group International
ASPHF · OTC
$4.53 +0.00% (+$0.00)
Market Cap ¥11.3B
P/E Ratio -
Div. Yield -
ROE 172.24%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 20.27x
P/B 8.55x
P/E N/A
Growth
100 /100
Growing Rev. growth 38.68%
Book val. growth 48.01%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 76.41%
FCF margin 214.86%
Net margin 216.47%
Quality
2 /100
Poor ROIC 33.50%
Asset turnover 0.14x
ROE 172.24%
Debt
37 /100
Moderate Debt/Equity 1.49x
Int. coverage -22.42x
Current ratio 1.79x
Stability
26 /100
Unstable Beta 0.66x
Profitable years 0
Rev. volatility 209.46%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ASPHF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dajun Yang
Employees
767
Headquarters
Suzhou
Nadcházející události
31 BŘE
Earnings
Upcoming earnings report